Effect of three beta-blockers with different pharmacological properties on metabolic, cardiovascular and hormonal response to insulin-induced hypoglycemia in normal subjects.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002096:C-Peptide / Q000097:blood; D002354:Carteolol / Q000494:pharmacology; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007003:Hypoglycemia / Q000097:blood* / Q000139:chemically induced / Q000503:physiopathology; D007328:Insulin; D007700:Kinetics; D008297:Male; D008790:Metoprolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D002354:Carteolol; D013006:Growth Hormone; D005934:Glucagon; D011433:Propranolol; D008790:Metoprolol; D006854:Hydrocortisone